PHARMACOKINETICS LIMITS CLINICAL USE OF IVERMECTIN FOR COVID-19
Ricardo Pena Silva and Sandra Jaramillo Rincon
Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVI...
Ricardo Pena Silva, Stephen Duffull, Andrew Steer, et al.